NHL |
non-Hodgkin’s lymphoma |
HLHL |
Hodgkin’s lymphoma |
HPLC-HRMS |
high-performance liquid chromatography |
NK |
natural killer |
B cells |
B lymphocytes |
T cells |
T lymphocytes |
WHO |
World Health Organization |
NLR |
neutrophil/lymphocyte ratio () |
dNLR |
derived NLR [= neutrophils/(white blood cells − neutrophils ratio)] |
PLR |
platelet/lymphocyte ratio |
MLR |
monocyte/lymphocyte ratio |
NLR |
neutrophil-to-lymphocyte ratio |
LMR |
lymphocyte-to-monocyte ratio |
SIRI |
(neutrophil × monocyte)/lymphocyte ratio |
AISI |
(neutrophil × monocyte × platelet)/lymphocyte ratio |
AMC |
absolute monocyte count |
IPI |
International Prognostic Index |
DLBCL |
diffuse large B-cell lymphoma |
MS |
mass spectrometry |
HPLC-HRMS |
high-performance liquid chromatography/high-resolution mass spectrometry |
HFBA |
Heptafluorobutyric acid |
QC |
quality control samples |
MAD |
median absolute deviation |
OPLS-DA |
orthogonal partial discriminant analysis of the minimum square |
PLS-DA |
partial least squares discriminant analysis |
VIP |
variable importance parameter |
WBC |
white blood cell |
RBC |
red blood cells |
HGB |
hemoglobin |
PLT |
platelet |
RDW |
red cell distribution |
NEUT |
neutrophils |
LYMPH |
lymphocytes |
MONO |
monocytes |
HBV |
Hepatitis B Virus |
HCV |
Hepatitis C Virus |
GABA |
gamma-aminobutyric acid |
SAM |
S-adenosylmethionine |